ArticleJournal of biomaterials applications2023

The use of commercial fibrin glue in dermal replacement material reduces angiogenic and lymphangiogenic gene and protein expression in vitro.

Benedikt Fuchs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.